C
Caregen Co Ltd
KOSDAQ:214370
Caregen Co Ltd
KOSDAQ:214370
Price:
28 450
KRW
2.71%
Market Cap:
1.4T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Caregen Co Ltd
28450
+750 (+2.71%)
| 52 Week Range |
15 400
28 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Caregen Co Ltd
Balance Sheet
Balance Sheet Decomposition
Caregen Co Ltd
Caregen Co Ltd
| Current Assets | 96.9B |
| Cash & Short-Term Investments | 55.8B |
| Receivables | 22.6B |
| Other Current Assets | 18.4B |
| Non-Current Assets | 145.5B |
| Long-Term Investments | 4.5B |
| PP&E | 127.1B |
| Intangibles | 4.9B |
| Other Non-Current Assets | 8.9B |
| Current Liabilities | 9.7B |
| Accounts Payable | 2.9B |
| Accrued Liabilities | 575.3m |
| Other Current Liabilities | 6.3B |
| Non-Current Liabilities | 9.1B |
| Other Non-Current Liabilities | 9.1B |
Balance Sheet
Caregen Co Ltd
Caregen Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
1
|
11
|
6
|
13
|
6
|
13
|
22 249
|
5 179
|
31 528
|
|
| Cash |
3
|
1
|
11
|
6
|
13
|
6
|
13
|
3
|
4
|
11
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22 246
|
5 176
|
31 517
|
|
| Short-Term Investments |
28 016
|
202 015
|
175 732
|
147 703
|
156 677
|
167 392
|
127 621
|
114 019
|
135 300
|
101 196
|
|
| Total Receivables |
5 466
|
12 616
|
24 795
|
32 346
|
3 222
|
3 722
|
5 815
|
6 154
|
7 638
|
14 184
|
|
| Accounts Receivables |
5 236
|
12 268
|
24 334
|
31 825
|
2 768
|
2 938
|
4 964
|
5 713
|
7 166
|
14 084
|
|
| Other Receivables |
230
|
348
|
461
|
521
|
454
|
784
|
851
|
442
|
473
|
100
|
|
| Inventory |
2 027
|
2 598
|
3 387
|
3 721
|
5 558
|
5 446
|
6 517
|
6 174
|
10 269
|
18 722
|
|
| Other Current Assets |
730
|
1 204
|
1 379
|
11 733
|
544
|
892
|
596
|
733
|
546
|
798
|
|
| Total Current Assets |
36 241
|
218 434
|
205 304
|
195 508
|
166 013
|
177 458
|
140 561
|
149 329
|
158 933
|
166 427
|
|
| PP&E Net |
15 021
|
26 081
|
26 441
|
34 977
|
35 646
|
40 717
|
59 962
|
62 111
|
60 407
|
63 996
|
|
| PP&E Gross |
15 021
|
26 081
|
26 441
|
34 977
|
35 646
|
40 717
|
59 962
|
62 111
|
60 407
|
63 996
|
|
| Accumulated Depreciation |
4 279
|
4 781
|
6 001
|
7 888
|
8 628
|
10 617
|
12 624
|
14 364
|
17 695
|
21 850
|
|
| Intangible Assets |
1 293
|
1 180
|
1 243
|
1 342
|
1 422
|
1 760
|
2 223
|
3 064
|
3 916
|
4 690
|
|
| Note Receivable |
0
|
1 552
|
1 295
|
1 165
|
1 055
|
1 443
|
1 322
|
1 293
|
1 034
|
950
|
|
| Long-Term Investments |
10 319
|
8 838
|
13 608
|
11 104
|
3 059
|
1 945
|
2 879
|
2 710
|
2 807
|
3 762
|
|
| Other Long-Term Assets |
274
|
433
|
1 243
|
2 927
|
11 743
|
8 525
|
9 609
|
8 254
|
6 972
|
7 451
|
|
| Total Assets |
63 148
N/A
|
256 517
+306%
|
249 134
-3%
|
247 023
-1%
|
218 938
-11%
|
231 847
+6%
|
216 556
-7%
|
226 760
+5%
|
234 070
+3%
|
247 277
+6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 063
|
945
|
929
|
1 698
|
3 750
|
311
|
434
|
908
|
1 900
|
890
|
|
| Accrued Liabilities |
60
|
172
|
225
|
273
|
789
|
1 554
|
963
|
2 149
|
2 179
|
2 406
|
|
| Short-Term Debt |
85
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
4 082
|
4 597
|
7 011
|
5 696
|
6 109
|
7 176
|
3 196
|
6 793
|
6 412
|
8 018
|
|
| Total Current Liabilities |
5 289
|
5 714
|
8 165
|
7 668
|
10 649
|
9 041
|
4 592
|
9 850
|
10 491
|
11 314
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
4 640
|
4 721
|
83
|
133
|
82
|
77
|
0
|
0
|
|
| Other Liabilities |
1 420
|
1 931
|
2 219
|
2 807
|
3 618
|
5 930
|
6 722
|
7 116
|
7 601
|
8 664
|
|
| Total Liabilities |
6 710
N/A
|
7 645
+14%
|
15 024
+97%
|
15 195
+1%
|
14 184
-7%
|
14 838
+5%
|
11 396
-23%
|
17 042
+50%
|
18 092
+6%
|
19 978
+10%
|
|
| Equity | |||||||||||
| Common Stock |
1 515
|
5 355
|
5 355
|
5 372
|
5 372
|
5 372
|
5 372
|
5 372
|
5 372
|
5 372
|
|
| Retained Earnings |
48 992
|
68 242
|
84 777
|
92 643
|
71 735
|
270 758
|
266 704
|
271 430
|
273 833
|
285 266
|
|
| Additional Paid In Capital |
4 757
|
173 719
|
173 719
|
175 498
|
175 498
|
4 544
|
4 544
|
4 544
|
5 682
|
5 761
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
183
|
549
|
845
|
840
|
1 086
|
517
|
330
|
|
| Treasury Stock |
0
|
0
|
0
|
39 666
|
45 854
|
60 169
|
68 746
|
68 746
|
67 278
|
67 211
|
|
| Other Equity |
1 174
|
1 556
|
29 741
|
2 201
|
1 447
|
2 651
|
1 874
|
1 797
|
1 113
|
1 559
|
|
| Total Equity |
56 438
N/A
|
248 872
+341%
|
234 110
-6%
|
231 828
-1%
|
204 754
-12%
|
217 009
+6%
|
205 160
-5%
|
209 718
+2%
|
215 978
+3%
|
227 299
+5%
|
|
| Total Liabilities & Equity |
63 148
N/A
|
256 517
+306%
|
249 134
-3%
|
247 023
-1%
|
218 938
-11%
|
231 847
+6%
|
216 556
-7%
|
226 760
+5%
|
234 070
+3%
|
247 277
+6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3
|
11
|
11
|
10
|
10
|
10
|
10
|
49
|
49
|
49
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
